Skip to main content

Table 5 Subgroup analyses on the impacts of volume (thousand DDD)

From: The impact of the national volume-based procurement policy on the use of policy-related drugs in Nanjing: an interrupted time-series analysis

Categories

Drugs under the same generic name

Alternative drugs

Bid-winning

Generic

Branded

Total

Perfect

Fundamental

Limited

Total

ATC-C

 Level change

4671.36***

-2300.95***

-2258.69***

295.69

329.47

-22.32

-0.19

0.13

 Trend change

201.28*

4.41

25.57

73.31

-2.95

46.58*

0.11*

0.15

ATC-N

 Level change

85.73

-115.02***

-125.61***

-86.42

-13.79*

-13.67

-0.53*

-557.76*

 Trend change

8.86

6.74*

-0.67

9.07

0.86

-0.21

0.05

47.70

ATC-J

 Level change

829.67***

-497.20***

-54.66***

246.62

1.30

-70.41

-47.83

-124.64

 Trend change

9.76

14.68

-6.70***

-3.45

1.04

11.69*

31.71**

44.60**

ATC-L

 Level change

38.44***

-44.74***

-2.21

-7.15

-

0.43

-0.33

0.06

 Trend change

1.29*

0.71

0.33

0.65

-

0.61***

-0.44

0.17

Others

 Level change

722.57***

-492.14***

-519.28***

-171.24

-

-

-8.47

-8.47

 Trend change

36.36**

5.68

2.86

12.50

-

-

1.60

1.60

  1. ***p-value < 0.001
  2. **p-value < 0.01
  3. *p-value < 0.05
  4. “Others” included ATC-A, ATC-B, ATC-M and ATC-R, due to the number of drugs in these categories extremely low